HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryutaro Kira Selected Research

Subacute Sclerosing Panencephalitis (SSPE)

1/2021Favorable outcomes of interferon-α and ribavirin treatment for a male with subacute sclerosing panencephalitis.
11/2008Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis.
8/2007[Host genetic factors for the development of SSPE].
1/2007Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis.
7/2005Gene expression profiles in peripheral blood mononuclear cells from patients with subacute sclerosing panencephalitis using oligonucleotide microarrays.
5/2002Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryutaro Kira Research Topics

Disease

6Subacute Sclerosing Panencephalitis (SSPE)
01/2021 - 05/2002
4Brain Diseases (Brain Disorder)
11/2022 - 07/2011
4Meningitis
01/2018 - 08/2002
3Infections
11/2022 - 04/2008
3Seizures (Absence Seizure)
07/2011 - 04/2009
3Febrile Seizures (Febrile Seizure)
04/2009 - 08/2005
2Epilepsy (Aura)
06/2021 - 04/2009
2Encephalitis (Encephalitis, Rasmussen)
06/2020 - 08/2002
2Leukocytosis (Pleocytosis)
10/2018 - 04/2008
2Paresthesia (Dysesthesia)
04/2008 - 01/2006
2Measles
08/2007 - 07/2005
2Genetic Predisposition to Disease (Genetic Predisposition)
08/2005 - 05/2002
1Apnea
11/2022
1Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
09/2021
1Optic Neuritis (Retrobulbar Neuritis)
06/2021
1Pain (Aches)
06/2021
1Cognitive Dysfunction
06/2021
1Demyelinating Diseases (Demyelinating Disease)
06/2021
1Neuritis (Polyneuritis)
06/2020
1Cerebral Hemorrhage
04/2020
1Menkes Kinky Hair Syndrome (Menkes Disease)
07/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2019
1Drug Resistant Epilepsy
04/2019
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
01/2019
1Infantile Spasms (West Syndrome)
01/2019
1Guillain-Barre Syndrome
10/2018
1Marshall-Smith syndrome
12/2017
1Sotos Syndrome
12/2017
1Megalencephaly
12/2017
1Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
01/2017
1Dermoid Cyst (Dermoid)
06/2016
1Abscess
06/2016
1Spina Bifida Occulta
06/2016
1Disease Progression
06/2013
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
07/2011
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
07/2011
1Sepsis (Septicemia)
06/2009
1Protein C Deficiency
06/2009
1Purpura Fulminans
06/2009
1Melanoma (Melanoma, Malignant)
11/2008
1Urinary Retention
04/2008
1Autoimmune Diseases (Autoimmune Disease)
04/2008
1Sjogren's Syndrome (Sjogren Syndrome)
04/2008
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
06/2006
1Paresis (Hemiparesis)
01/2006
1Moyamoya Disease (Moya-Moya Disease)
01/2006

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
04/2009 - 05/2002
2Immunoglobulin G (IgG)IBA
06/2021 - 06/2020
2InterferonsIBA
01/2021 - 05/2002
2AntibodiesIBA
10/2018 - 06/2013
2Proteins (Proteins, Gene)FDA Link
12/2017 - 11/2008
2Interleukin-1beta (Interleukin 1 beta)IBA
04/2009 - 08/2005
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2007 - 07/2005
2OligonucleotidesIBA
08/2007 - 07/2005
2Messenger RNA (mRNA)IBA
08/2007 - 07/2005
1N-(2-cyanoethylene)urea (BA 1)IBA
11/2022
1Myelin-Oligodendrocyte GlycoproteinIBA
06/2021
1Ribavirin (Virazole)FDA LinkGeneric
01/2021
1carbazochrome (Adona)IBA
04/2020
1CopperIBA
07/2019
1AutoantibodiesIBA
01/2019
1Intrinsic FactorFDA Link
01/2019
1InterleukinsIBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1Glycoproteins (Glycoprotein)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Leucine (L-Leucine)FDA Link
01/2018
1NFI Transcription FactorsIBA
12/2017
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2017
1Topiramate (Topamax)FDA LinkGeneric
01/2017
1Acetazolamide (Diamox)FDA LinkGeneric
01/2017
1Capsules (Microcapsules)IBA
06/2016
1Quinidine (Chinidin)FDA LinkGeneric
03/2016
1GlucocorticoidsIBA
07/2011
1Hydrocortisone (Cortisol)FDA LinkGeneric
07/2011
1Blood Proteins (Serum Proteins)IBA
06/2009
1Protein CIBA
06/2009
1Hemostatics (Antihemorrhagics)IBA
06/2009
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
04/2009
1Interleukin-10 (Interleukin 10)IBA
04/2009
1Toll-Like Receptor 3IBA
11/2008
1Double-Stranded RNA (RNA, Double Stranded)IBA
11/2008
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2008
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2008
1Tacrolimus (Prograf)FDA LinkGeneric
04/2008
1Immunoglobulin M (IgM)IBA
04/2008
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2007
1Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA
08/2007
1Matrix Metalloproteinases (MMPs)IBA
01/2007
1Metalloproteases (Metalloproteinases)IBA
01/2007
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2007
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2007
1ChemokinesIBA
06/2006

Therapy/Procedure

5Therapeutics
07/2019 - 03/2003
2Induced Hyperthermia (Thermotherapy)
04/2009 - 04/2009
1Artificial Respiration (Mechanical Ventilation)
11/2022
1Transplantation
09/2021
1Intraventricular Infusions
01/2021
1Critical Care (Surgical Intensive Care)
04/2019
1Splenectomy
01/2006